NICE’s Preparations for Evaluating New Al...

By HEOR Staff Writer

December 27, 2023

The Advent of Disease-Modifying Dementia Treatments (DMDTs) Recent years have seen significant strides in our understanding of dementia, particularly
AI’s Approaches to Maternal and Neonatal Health in Low Resource Settings
Reassessing the Impact of Demographic Representation on Clinical Development ...
The Cost-Effectiveness of Efgartigimod Alfa (Vyvgart) in the Treatment of Mya...
Access to AI in Medical Education: Innovating and Inclusive
A New Dawn in Breast Cancer Treatment: Ultra-Hypofractionated Radiotherapy
Spinal Muscular Atrophy: A Comprehensive Review of Newborn Screening, Treatme...
The Value-Based Pricing and Market Access of Valbenazine: A Cost Effective Ev...
Navigating the Maze: The EU Pharma Legislation Review and its Implications
The Power of Telehealth and CGM Technology in Diabetes Management
The Future of Healthcare: The Potential and Challenges of Virtual Wards
Medical Device Procurement: Unravelling the Role of Health Technology Assessment
ISPOR CEO Rob Abbott Advocates for HEOR in Global Healthcare Decision Making